June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Immune response of the Cornea after Descemet Membrane Endothelial Keratoplasty (DMEK) vs. Penetrating Keratoplasty (PK)
Author Affiliations & Notes
  • Björn Bachmann
    Ophthalmology, University of Cologne, Cologne, Germany
  • Footnotes
    Commercial Relationships   Björn Bachmann DMEK shooter system, PCT/EP2017/000748, no company, Code P (Patent), Heidelberg Engineering, Code R (Recipient)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1292. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Björn Bachmann; Immune response of the Cornea after Descemet Membrane Endothelial Keratoplasty (DMEK) vs. Penetrating Keratoplasty (PK). Invest. Ophthalmol. Vis. Sci. 2023;64(8):1292.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Presentation Description : Immune reactions after corneal transplantation have decreased significantly after the widespread introduction of lamellar grafting techniques. Endothelial rejection is the principal cause of graft failure after normal-risk penetrating keratoplasty (PK) and it also occurs at much lower rate after normal-risk Descemet Membrane Endothelial Keratoplasty (DMEK). After PK, endothelial rejection lines (Khodadoust lines) often originate from corneal neovascularizations. In contrast to PK, Khodadoust lines are rare in rejections after DMEK. These patients might still have very good vision despite increasing amounts of keratic precipitates over weeks or months and the diagnosis of rejection is frequently made by chance during routine examinations. Little is known about the factors that cause the lower rate of immune responses after DMEK. Differences between the two transplantation techniques that may have an impact on the development of rejection include suture-induced angiogenesis, the extent of disruption of the blood-aqueous barrier caused by the surgery, the distance of transplanted tissue from the recipient's vascular bed, and the transplantation of donor antigen-presenting cells.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×